Nanozymes: The Emerging Frontier in Catalytic Nanomaterials and Their Therapeutic Applications

Artificial nanomaterials known as nanozymes, which possess inherent enzyme-mimetic characteristics, have transformed environmental research, biomedicine, and catalysis. Compared with natural enzymes, nanozymes are advantageous due to their high stability, low cost, and adaptability. They exhibit oxidation, reduction, peroxidation, and superoxide dismutation activities, which are essential for environmental remediation, disease therapy, and biological diagnostics. Recent developments have further broadened their catalytic capabilities. Nanozyme-based biosensors offer high sensitivity and rapid detection of biomarkers for diseases such as cancer, diabetes, and infectious disorders, significantly improving early disease diagnosis. In therapeutics, nanozymes play a critical role in regulating oxidative stress, enabling targeted drug delivery, and supporting antibacterial treatments. Their ability to mimic peroxidase and catalase activities has greatly enhanced photodynamic therapy, immunotherapy, and neuroprotection strategies. Despite these advances, challenges remain in improving catalytic efficiency, biocompatibility, and target specificity. Safe clinical translation requires addressing issues related to immunogenicity, long-term toxicity, and controlled biodegradability. Advances in surface modification, functionalization, and AI-driven nanozyme design have improved selectivity and therapeutic performance. Integrating nanozymes with bioinformatics, artificial intelligence, and nanomedicine has opened new avenues for precision healthcare, including real-time disease monitoring and personalized treatment strategies. This review highlights the transformative impact of nanozymes in industrial and medical applications by examining recent advances, challenges, and future prospects in the field. With continued development, nanozymes have the potential to revolutionize enzyme-based technologies, making them indispensable to modern science and medicine.

Authors

Institutions

Publication Details

Journal
Recent Advances in Drug Delivery and Formulation
Published
2026-03-13
DOI
https://doi.org/10.2174/0126673878406314251127055108
Primary Topic
Advanced Nanomaterials in Catalysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nanozymes: The Emerging Frontier in Catalytic Nanomaterials and Their Therapeutic Applications

Anu Hardenia, Pratibha Bhide, Asraf Khan, Purvi Chaturvedi et al.
Recent Advances in Drug Delivery and Formulation
Advanced Nanomaterials in Catalysis
article

Nanozymes: The Emerging Frontier in Catalytic Nanomaterials and Their Therapeutic Applications

Anu Hardenia, Pratibha Bhide, Asraf Khan, Purvi Chaturvedi, Sunil Kumar Dwivedi, Ashish Kumar Parashar
article en

Abstract

Artificial nanomaterials known as nanozymes, which possess inherent enzyme-mimetic characteristics, have transformed environmental research, biomedicine, and catalysis. Compared with natural enzymes, nanozymes are advantageous due to their high stability, low cost, and adaptability. They exhibit oxidation, reduction, peroxidation, and superoxide dismutation activities, which are essential for environmental remediation, disease therapy, and biological diagnostics. Recent developments have further broadened their catalytic capabilities. Nanozyme-based biosensors offer high sensitivity and rapid detection of biomarkers for diseases such as cancer, diabetes, and infectious disorders, significantly improving early disease diagnosis. In therapeutics, nanozymes play a critical role in regulating oxidative stress, enabling targeted drug delivery, and supporting antibacterial treatments. Their ability to mimic peroxidase and catalase activities has greatly enhanced photodynamic therapy, immunotherapy, and neuroprotection strategies. Despite these advances, challenges remain in improving catalytic efficiency, biocompatibility, and target specificity. Safe clinical translation requires addressing issues related to immunogenicity, long-term toxicity, and controlled biodegradability. Advances in surface modification, functionalization, and AI-driven nanozyme design have improved selectivity and therapeutic performance. Integrating nanozymes with bioinformatics, artificial intelligence, and nanomedicine has opened new avenues for precision healthcare, including real-time disease monitoring and personalized treatment strategies. This review highlights the transformative impact of nanozymes in industrial and medical applications by examining recent advances, challenges, and future prospects in the field. With continued development, nanozymes have the potential to revolutionize enzyme-based technologies, making them indispensable to modern science and medicine.

Recent Advances in Drug Delivery and FormulationVol. 20
Institute of Management Technology (IN), Aurobindo Pharma (India) (IN), Sri Aurobindo Institute of Technology (IN), Sri Aurobindo Institute of Medical Sciences (IN)
Openalex Percentile: Top 22%
Advanced Nanomaterials in Catalysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.